Cargando…
The Effect of TNF-α Blocker HL036337 and Its Best Concentration to Inhibit Dry Eye Inflammation
PURPOSE: Dry eye syndrome is commonly thought of as an inflammatory disease, and we have previously presented data showing the effectiveness of topical TNF-α blocker agents for the treatment of this condition. The purpose of this study was to investigate the effectiveness of the TNF-α blocking agent...
Autores principales: | Choi, Wungrak, Noh, Hyemi, Yeo, Areum, Jang, Hanmil, Ahn, Hyea Kyung, Song, Yeon Jung, Lee, Hyung Keun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965606/ https://www.ncbi.nlm.nih.gov/pubmed/27478358 http://dx.doi.org/10.3341/kjo.2016.30.4.302 |
Ejemplares similares
-
Activation of Dll4/Notch Signaling and Hypoxia-Inducible Factor-1 Alpha Facilitates Lymphangiogenesis in Lacrimal Glands in Dry Eye
por: Min, Ji Hwan, et al.
Publicado: (2016) -
Langerhans cells prevent subbasal nerve damage and upregulate neurotrophic factors in dry eye disease
por: Choi, Eun Young, et al.
Publicado: (2017) -
Comparison of Treatment Modalities for Dry Eye in Primary Sjögren’s Syndrome
por: Ahn, Hyunmin, et al.
Publicado: (2022) -
CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017) -
Impact of Lacrimal Gland Extraction on the Contralateral Eye in an Animal Model for Dry Eye Disease
por: Kim, Minha, et al.
Publicado: (2022)